Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
6
×
biotech
boston blog main
boston top stories
6
×
boulder/denver blog main
boulder/denver top stories
cancer
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
startups
cancer immunotherapy
deals
eli lilly
medicare
novartis
pfizer
aduro biotech
bristol-myers squibb
clinical trials
What
bio
roundup
drug
alzheimer’s
companies
gene
new
price
prices
talk
activity
alliance
annual
approval
approvals
assessed
attention
becker
billions
biogen
biogen’s
biopharmaceutical
biotech
bristol
buy
calls
changing
clamped
color
communities
conference
convo
covid
crispr
days
delays
developing
different
dollars
earlier
Language
unset
Current search:
biogen
×
cancer
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More